Gh Research PLC (GHRS) intrinsic value & 10-year financials
Gh Research PLC (GHRS) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 21, 2026)
- $19.17
- Market cap
- $1.2B
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- -20.1%
- Free cash flow (FY2025)
- -$43.7M
GHRS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$48.3M | -$0.79 | -$43.7M | — | -21.0% |
| FY2024 | — | -$39.0M | -$0.75 | -$42.3M | — | -19.6% |
| FY2023 | — | -$35.6M | -$0.68 | -$33.4M | — | -15.2% |
| FY2022 | — | -$22.5M | -$0.43 | -$26.3M | — | -8.5% |
| FY2021 | — | -$9.2M | -$0.21 | -$15.4M | — | -6.5% |
| FY2020 | — | -$446.0K | -$0.02 | — | — | -14.7% |
| FY2019 | — | -$310.0K | -$0.01 | — | — | -55.3% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
GH Research PLC revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
GH Research PLC has historically struggled to out-earn its cost of capital, averaging just -20.1% ROIC.
GH Research PLC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
GH Research PLC is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.